Penetrance is a critical parameter for assessing the disease liability of CFTR variants

Autor: Boussaroque, A., Audrézet, M.-P., Raynal, C., Sermet-Gaudelus, I., Bienvenu, T., Férec, C., Bergougnoux, A., Lopez, M., Scotet, V., Munck, A., Girodon, E.
Zdroj: In Journal of Cystic Fibrosis November 2020 19(6):949-954
Databáze: ScienceDirect